Physician profile
Carlos E Rojas
NPI 1326232216
$5,584.28
in general payments reported to CMS, 2019-2025
16 companies · $28.06 in 2025
The $28.06 reported for 2025 was less than what a typical Hospitalist provider received nationally (typical 2025 total: $85.87).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,003 · 2020: $57.38 · 2021: $64.86 · 2022: $147 · 2023: $188 · 2024: $96.18 · 2025: $28.06.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $312.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $312.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bristol Myers Squibb Company | $4,815.00 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $113.96 | 2019-2023 | Camzyos |
| Tei Medical INC. | $112.45 | 2019 | |
| Novartis Pharmaceuticals Corporation | $107.54 | 2022-2024 | |
| Alnylam Pharmaceuticals INC. | $90.95 | 2023 | Onpattro |
| Janssen Pharmaceuticals, INC | $70.60 | 2021-2024 | Xarelto |
| Pfizer INC. | $55.81 | 2019-2022 | |
| Allergan, INC. | $42.47 | 2020 | |
| Abbvie INC. | $40.18 | 2022-2025 | |
| Astrazeneca Pharmaceuticals LP | $21.15 | 2019 | |
| Aimmune Therapeutics, INC. | $20.90 | 2024 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $20.89 | 2024 | Xifaxan |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $20.25 | 2021 | |
| Alexion Pharmaceuticals, INC. | $19.35 | 2023 | Ultomiris |
| Lexicon Pharmaceuticals, INC. | $17.87 | 2024 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $14.91 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Carlos Rojas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.